Giovannelli e Associati with Broletto Corporate Advisory on the investment in Finlab14/11/2022
Giovannelli e Associati with 360 Capital Partners on the round of investment in Sinergy Flow22/11/2022
Giovannelli e Associati is advising Ardian on its reinvestment, together with NB Renaissance, jointly holding a majority stake in the share capital of Neopharmed Gentili, a pharmaceutical company specializing in the commercialization of high-value therapeutic solutions formerly. Mediolanum Farmaceutici will maintain a significant stake in the group.
Our team was led by partner Fabrizio Scaparro, and included senior associate Paola Pagani, associates Lilia Montella and Matteo Bruni and trainees Alessandra Gritti e Filippo Noci for corporate aspects, partner Riccardo Pontremoli and trainee Carlo Pilia for regulatory matters, partner Alessandra Feller and associate Ginevra Lombardi for IP and Privacy aspects and of counsel Giuseppe Matarazzo and trainee Katie Pesenti for labor matters.